Navarra, A.; Cicalini, S.; D’Arezzo, S.; Pica, F.; Selleri, M.; Nisii, C.; Venditti, C.; Cannas, A.; Mazzarelli, A.; Vulcano, A.;
et al. Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting. Antibiotics 2025, 14, 304.
https://doi.org/10.3390/antibiotics14030304
AMA Style
Navarra A, Cicalini S, D’Arezzo S, Pica F, Selleri M, Nisii C, Venditti C, Cannas A, Mazzarelli A, Vulcano A,
et al. Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting. Antibiotics. 2025; 14(3):304.
https://doi.org/10.3390/antibiotics14030304
Chicago/Turabian Style
Navarra, Assunta, Stefania Cicalini, Silvia D’Arezzo, Francesca Pica, Marina Selleri, Carla Nisii, Carolina Venditti, Angela Cannas, Antonio Mazzarelli, Antonella Vulcano,
and et al. 2025. "Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting" Antibiotics 14, no. 3: 304.
https://doi.org/10.3390/antibiotics14030304
APA Style
Navarra, A., Cicalini, S., D’Arezzo, S., Pica, F., Selleri, M., Nisii, C., Venditti, C., Cannas, A., Mazzarelli, A., Vulcano, A., Carrara, S., Vincenti, D., Bartolini, B., Giacomini, P., Bocci, M. G., & Fontana, C.
(2025). Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting. Antibiotics, 14(3), 304.
https://doi.org/10.3390/antibiotics14030304
